Lamictal (lamotrigine) Chewable Dispersible Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved June 1999

Specific Treatments:

Neurology

Therapeutic Areas

General Information

The approval of these efficacy supplements provide for the use of Lamictal as conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug.